Patent · US Active

Modulation of hepatitis B virus (HBV) expression

US9034841B2 · kind B2 · utility

9Cited by
38References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2013
Grant dateMay 19, 2015
Priority date—
Expiry dateDec 20, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are antisense compounds and methods for decreasing HBV mRNA, DNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate HBV-related diseases, disorders or conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.